M1 and M2 Muscarinic Receptor Subtypes Regulate Antidepressant-Like Effects of the Rapidly Acting Antidepressant Scopolamine-Reference-Cited by-同舟云学术

M1 and M2 Muscarinic Receptor Subtypes Regulate Antidepressant-Like Effects of the Rapidly Acting Antidepressant Scopolamine

Published:2014-09-03 Issue:2 Volume:351 Page:448-456
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Witkin J. M.,Overshiner C.,Li X.,Catlow J. T.,Wishart G. N.,Schober D. A.,Heinz B. A.,Nikolayev A.,Tolstikov V. V.,Anderson W. H.,Higgs R. E.,Kuo M.-S.,Felder C. C.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference59 articles.

1. A role for AMPA receptors in mood disorders

2. SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability

3. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

4. Antidepressant effects of ketamine in depressed patients

5. Identification of a Family of Muscarinic Acetylcholine Receptor Genes

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ameliorative effect of vanillic acid against scopolamine-induced learning and memory impairment in rat via attenuation of oxidative stress and dysfunctional synaptic plasticity;Biomedicine & Pharmacotherapy;2024-08

2. Subchronic administration of scopolamine reverses UCMS-induced behavior in mice via eEF2 protein dephosphorylation;Pharmacological Reports;2024-07-23

3. Differential effects of intra-RMTg infusions of pilocarpine or 4-DAMP on regulating depression- and anxiety-like behaviors;Behavioural Brain Research;2024-03

4. Design, Synthesis, and Activity Evaluation of Fluorine-Containing Scopolamine Analogues as Potential Antidepressants;Journal of Medicinal Chemistry;2024-02-14

5. Erratum for the Research Article: “Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC”;Science Advances;2023-11-17